2023-04-012024-03-312024-03-31false08035351JELLY BEANS MONTESSORI NURSERY LIMITED2024-10-14iso4217:GBPxbrli:pure080353512023-04-01080353512024-03-31080353512023-04-012024-03-31080353512022-04-01080353512023-03-31080353512022-04-012023-03-3108035351bus:SmallEntities2023-04-012024-03-3108035351bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3108035351bus:AbridgedAccounts2023-04-012024-03-3108035351bus:PrivateLimitedCompanyLtd2023-04-012024-03-3108035351core:WithinOneYear2024-03-3108035351core:AfterOneYear2024-03-3108035351core:WithinOneYear2023-03-3108035351core:AfterOneYear2023-03-3108035351core:ShareCapital2024-03-3108035351core:SharePremium2024-03-3108035351core:RevaluationReserve2024-03-3108035351core:OtherReservesSubtotal2024-03-3108035351core:RetainedEarningsAccumulatedLosses2024-03-3108035351core:ShareCapital2023-03-3108035351core:SharePremium2023-03-3108035351core:RevaluationReserve2023-03-3108035351core:OtherReservesSubtotal2023-03-3108035351core:RetainedEarningsAccumulatedLosses2023-03-3108035351core:LandBuildings2024-03-3108035351core:PlantMachinery2024-03-3108035351core:Vehicles2024-03-3108035351core:FurnitureFittings2024-03-3108035351core:OfficeEquipment2024-03-3108035351core:NetGoodwill2024-03-3108035351core:IntangibleAssetsOtherThanGoodwill2024-03-3108035351core:ListedExchangeTraded2024-03-3108035351core:UnlistedNon-exchangeTraded2024-03-3108035351core:LandBuildings2023-03-3108035351core:PlantMachinery2023-03-3108035351core:Vehicles2023-03-3108035351core:FurnitureFittings2023-03-3108035351core:OfficeEquipment2023-03-3108035351core:NetGoodwill2023-03-3108035351core:IntangibleAssetsOtherThanGoodwill2023-03-3108035351core:ListedExchangeTraded2023-03-3108035351core:UnlistedNon-exchangeTraded2023-03-3108035351core:LandBuildings2023-04-012024-03-3108035351core:PlantMachinery2023-04-012024-03-3108035351core:Vehicles2023-04-012024-03-3108035351core:FurnitureFittings2023-04-012024-03-3108035351core:OfficeEquipment2023-04-012024-03-3108035351core:NetGoodwill2023-04-012024-03-3108035351core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108035351core:ListedExchangeTraded2023-04-012024-03-3108035351core:UnlistedNon-exchangeTraded2023-04-012024-03-3108035351core:MoreThanFiveYears2023-04-012024-03-3108035351core:Non-currentFinancialInstruments2024-03-3108035351core:Non-currentFinancialInstruments2023-03-3108035351dpl:CostSales2023-04-012024-03-3108035351dpl:DistributionCosts2023-04-012024-03-3108035351core:LandBuildings2023-04-012024-03-3108035351core:PlantMachinery2023-04-012024-03-3108035351core:Vehicles2023-04-012024-03-3108035351core:FurnitureFittings2023-04-012024-03-3108035351core:OfficeEquipment2023-04-012024-03-3108035351dpl:AdministrativeExpenses2023-04-012024-03-3108035351core:NetGoodwill2023-04-012024-03-3108035351core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108035351dpl:GroupUndertakings2023-04-012024-03-3108035351dpl:ParticipatingInterests2023-04-012024-03-3108035351dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3108035351core:ListedExchangeTraded2023-04-012024-03-3108035351dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3108035351core:UnlistedNon-exchangeTraded2023-04-012024-03-3108035351dpl:CostSales2022-04-012023-03-3108035351dpl:DistributionCosts2022-04-012023-03-3108035351core:LandBuildings2022-04-012023-03-3108035351core:PlantMachinery2022-04-012023-03-3108035351core:Vehicles2022-04-012023-03-3108035351core:FurnitureFittings2022-04-012023-03-3108035351core:OfficeEquipment2022-04-012023-03-3108035351dpl:AdministrativeExpenses2022-04-012023-03-3108035351core:NetGoodwill2022-04-012023-03-3108035351core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3108035351dpl:GroupUndertakings2022-04-012023-03-3108035351dpl:ParticipatingInterests2022-04-012023-03-3108035351dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3108035351core:ListedExchangeTraded2022-04-012023-03-3108035351dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3108035351core:UnlistedNon-exchangeTraded2022-04-012023-03-3108035351core:NetGoodwill2024-03-3108035351core:IntangibleAssetsOtherThanGoodwill2024-03-3108035351core:LandBuildings2024-03-3108035351core:PlantMachinery2024-03-3108035351core:Vehicles2024-03-3108035351core:FurnitureFittings2024-03-3108035351core:OfficeEquipment2024-03-3108035351core:AfterOneYear2024-03-3108035351core:WithinOneYear2024-03-3108035351core:ListedExchangeTraded2024-03-3108035351core:UnlistedNon-exchangeTraded2024-03-3108035351core:ShareCapital2024-03-3108035351core:SharePremium2024-03-3108035351core:RevaluationReserve2024-03-3108035351core:OtherReservesSubtotal2024-03-3108035351core:RetainedEarningsAccumulatedLosses2024-03-3108035351core:NetGoodwill2023-03-3108035351core:IntangibleAssetsOtherThanGoodwill2023-03-3108035351core:LandBuildings2023-03-3108035351core:PlantMachinery2023-03-3108035351core:Vehicles2023-03-3108035351core:FurnitureFittings2023-03-3108035351core:OfficeEquipment2023-03-3108035351core:AfterOneYear2023-03-3108035351core:WithinOneYear2023-03-3108035351core:ListedExchangeTraded2023-03-3108035351core:UnlistedNon-exchangeTraded2023-03-3108035351core:ShareCapital2023-03-3108035351core:SharePremium2023-03-3108035351core:RevaluationReserve2023-03-3108035351core:OtherReservesSubtotal2023-03-3108035351core:RetainedEarningsAccumulatedLosses2023-03-3108035351core:NetGoodwill2022-04-0108035351core:IntangibleAssetsOtherThanGoodwill2022-04-0108035351core:LandBuildings2022-04-0108035351core:PlantMachinery2022-04-0108035351core:Vehicles2022-04-0108035351core:FurnitureFittings2022-04-0108035351core:OfficeEquipment2022-04-0108035351core:AfterOneYear2022-04-0108035351core:WithinOneYear2022-04-0108035351core:ListedExchangeTraded2022-04-0108035351core:UnlistedNon-exchangeTraded2022-04-0108035351core:ShareCapital2022-04-0108035351core:SharePremium2022-04-0108035351core:RevaluationReserve2022-04-0108035351core:OtherReservesSubtotal2022-04-0108035351core:RetainedEarningsAccumulatedLosses2022-04-0108035351core:AfterOneYear2023-04-012024-03-3108035351core:WithinOneYear2023-04-012024-03-3108035351core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3108035351core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3108035351core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3108035351core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3108035351core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3108035351core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3108035351core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108035351core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108035351core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108035351core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3108035351core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3108035351core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3108035351core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3108035351core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3108035351core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3108035351core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3108035351core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3108035351core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3108035351core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3108035351core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3108035351core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3108035351core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3108035351core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3108035351core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3108035351core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3108035351core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3108035351core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3108035351bus:Director12023-04-012024-03-31

JELLY BEANS MONTESSORI NURSERY LIMITED

Registered Number
08035351
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

JELLY BEANS MONTESSORI NURSERY LIMITED
Company Information
for the year from 1 April 2023 to 31 March 2024

Director

DRUMMOND, Sarah Nicole

Registered Address

The Old Granary
Dunton Road
Basildon
SS15 4DB

Registered Number

08035351 (England and Wales)
JELLY BEANS MONTESSORI NURSERY LIMITED
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets4126,31893,388
126,31893,388
Current assets
Debtors5171,3309,595
Cash at bank and on hand120,69184,557
292,02194,152
Creditors amounts falling due within one year6(264,749)(128,573)
Net current assets (liabilities)27,272(34,421)
Total assets less current liabilities153,59058,967
Creditors amounts falling due after one year7(11,708)(21,730)
Net assets141,88237,237
Capital and reserves
Called up share capital100100
Profit and loss account141,78237,137
Shareholders' funds141,88237,237
The financial statements were approved and authorised for issue by the Director on 14 October 2024, and are signed on its behalf by:
DRUMMOND, Sarah Nicole
Director
Registered Company No. 08035351
JELLY BEANS MONTESSORI NURSERY LIMITED
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows: Goodwill - 10% straight line If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20242023
Average number of employees during the year4240
3.Intangible assets

Total

£
Cost or valuation
At 01 April 2330,000
At 31 March 2430,000
Amortisation and impairment
At 01 April 2330,000
At 31 March 2430,000
Net book value
At 31 March 24-
At 31 March 23-
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 23197,328
Additions59,660
At 31 March 24256,988
Depreciation and impairment
At 01 April 23103,940
Charge for year26,730
At 31 March 24130,670
Net book value
At 31 March 24126,318
At 31 March 2393,388
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables-9,595
Amounts owed by associates and joint ventures / participating interests171,330-
Total171,3309,595
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables15,00753,014
Bank borrowings and overdrafts80,490490
Taxation and social security118,58035,881
Other creditors50,67239,188
Total264,749128,573
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts11,70821,730
Total11,70821,730
Long term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.